Hence for this study we used our anti-PD1-resistant abscopal 344SQ cancer model (5) to characterize GITR expression and determine whether combining radiation therapy with anti-GITR and anti-PD1 antibodies could elicit an abscopal response. Here, TNFRSF18 is linked to cancer.